Chris Pernie
About Chris Pernie
Chris Pernie is the Executive Director of Government Affairs at Novo Nordisk with over 20 years of experience in government affairs and policy.
Current Role at Novo Nordisk
Chris Pernie is currently serving as the Executive Director of Government Affairs at Novo Nordisk. He joined the company in March 2021. In this position, he is responsible for overseeing the company's interactions with government entities, shaping public policy, and ensuring compliance with regulatory requirements in the United States. Chris brings over two decades of experience in government affairs and policy to his role, making him a key asset to Novo Nordisk's strategic initiatives.
Previous Experience at Bristol-Myers Squibb
Chris Pernie had a significant tenure at Bristol-Myers Squibb, where he held multiple key roles over a span of 17 years. He served as the Head of Federal Policy & Government Affairs from 2015 to 2021, based in the Washington D.C. Metro Area. Prior to this role, he was the Director of Federal Affairs at the same company from 2004 to 2015. His work focused on federal policy within the pharmaceutical industry, where he played a pivotal role in government relations and policy formation.
Early Career at U.S. House of Representatives
Chris Pernie began his career in government affairs at the U.S. House of Representatives, where he worked as a Legislative Assistant for six years, from 1998 to 2004. This role provided him with a foundational understanding of legislative processes and government operations, which he later leveraged in his subsequent positions within the pharmaceutical sector.
Educational Background
Chris Pernie holds a Bachelor of Arts degree in Government and Politics from the University of Maryland. He completed his studies in three years, from 1995 to 1998. His academic background in government and politics has provided him with a strong foundation for his extensive career in government affairs and policy.
Expertise in Government Affairs and Policy
With over 20 years of experience in government affairs and policy, Chris Pernie has built a comprehensive expertise in this field. Transitioning from a legislative role to impactful positions within major pharmaceutical companies, he has extensively worked on federal policy and government affairs. His career has been marked by significant contributions to shaping public policy and regulatory compliance within the highly-regulated pharmaceutical industry.